Test Bank for Pharmacotherapeutics for Advanced Practice Nurse Prescribers 6th Edition (F.A Davis, 2024) by Teri M. Woo And Wendy L. Wright, Isbn no; 9781719648035, all 60 Chapters Covered (2025 UPDATED)

, Table of content x@ x@




Chapter I Issues for the Practitioner in Drug Therapy
x@ x@ x@ x@ x@ x@ x@ x@



Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Princip
x@ x@ x@ x@ x@ x@ x@ x@



les Chapter 3 Impact of Drug Interactions and Adverse Events on Therape
x@ x@ x @ x@ x@ x@ x @ x@ x@ x @ x@



utics Chapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@



Lactation Chapter 5 Pharmacotherapy Principles in Older Adults
x@ x@ x@ x@ x@ x@ x@



Chapter 6 Principles of Antimicrobial Therapy Cha
x@ x@ x@ x@ x@ x@



pter 7 Pharmacogenomies
x@ x@



Chapter 8 The Economics of Pharmacotherapeutics
x@ x@ x@ x@ x@ x



@Chapter 9 Pharmacotherapy of Pain Management
x@ x@ x@ x@ x@



Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patie
x@ x@ x@ x@ x@ x@ x@ x@ x@



nts Chapter 11 Cannabis and Pain Management
x@ x@ x@ x@ x@ x@



Chapter 12 Contact Dermatitis
x@ x@ x@



Chapter 13 Fungal, Viral, and Bacterial Infections of the S
x@ x@ x@ x@ x@ x@ x@ x@ x@



kin Chapter 14 Psoriasis
x@ x@ x@



Chapter I5 Acne Vulgaris and Rosacea Ch
x@ x@ x@ x@ x@ x@



apter 16 Ophthalmic Disorders
x@ x@ x@



Chapter I7 Otitis Media and Otitis Externa
x@ x@ x@ x@ x@ x@ x



@Chapter I8 Hypertension x@ x@



Chapter I9 Hyperlipidemiax@ x@



Chapter 20 Chronic Stable Angina and Myocardial Infarcti
x@ x@ x@ x@ x@ x@ x@



on Chapter 2I Heart Failure
x@ x@ x@ x@



Chapter 22 Arrhythmias x@ x@



Chapter 23 Respiratory Infections
x@ x@ x@



Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease C
x@ x@ x@ x@ x@ x@ x@ x@



hapter 25 Gastric, Functional, and Inflammatory Bowel Disorders
x@ x@ x@ x@ x@ x@ x@ x@



Chapter 26 Gastroesophageal Reflux Disease and Peptic Ulcer Dise
x@ x@ x@ x@ x@ x@ x@ x@



ase Chapter 27 Liver Diseases
x@ x@ x@ x@



Chapter 28 Urinary Tract Infection
x@ x@ x@ x@



Chapter 29 Prostatic Disorders and Erectile Dysfunction Ch
x@ x@ x@ x@ x@ x@ x@



apter 30 Overactive Bladder
x@ x@ x@



Chapter 3I Sexually Transmitted Infectio
x@ x@ x@ x@



ns Chapter 32 Osteoarthritis and Gout
x@ x@ x@ x@ x@ x@



Chapter 33 Osteoporosis x@ x@



Chapter 34 Rheumatoid Arthritis
x@ x@ x@ x



@Chapter 35 Headaches x@ x@



Chapter 36 Seizure Disorders
x@ x@ x@



Chapter 37 Alzheimer's Diseas
x@ x@ x@ x@



e Chapter 38 Parkinson's Di
x @ x@ x@ x@



sease
Chapter 39 Major Depressive Disorder and Bipolar Disorde
x@ x@ x@ x@ x@ x@ x@



rs Chapter 40 Anxiety Disorders
x@ x@ x@ x@



Chapter 41 Sleep Disorders
x@ x @ x @


Chapter 42 Attention Deficit Hyperactivity Disorde
x@ x@ x@ x@ x@



r Chapter 43 Substance Use Disorders
x@ x@ x@ x@ x@



Chapter 44 Diabetes Mellitus
x@ x@ x@



Chapter 45 Thyroid and Parathyroid Disorders
x@ x@ x@ x@ x@

,Chapter 46 Allergies and Allergic Reactio
x@ x@ x@ x@ x@



ns Chapter 47 Human Immunodeficiency
x@ x@ x@ x@ x@



Virus Chapter 48 Organ Transplantation
x@ x@ x@ x@



Chapter 49 Thromboembolic Disorders C
x@ x@ x@ x@



hapter 50 Anemias x@ x@



Chapter 5l Immunizations Cha
x@ x@ x@



pter 52 Smoking Cessation Ch
x@ x@ x@ x@



apter 53 Weight Loss Chapter
x@ x@ x@ x@



54 Contraception
x@ x@



Chapter 55 Menopause x@ x@



Chapter 56 Vaginitis x@ x@

, lOMoAR cPSD| 21007614




x @ x@
lOMoAR cPSD| 21007614




Chapter 1 Issues for the Practitioner in Drug Therapy
x@ x@ x@ x@ x@ x@ x@ x@




MULTIPLE CHOICE
x@




1. Nurse practitioner prescriptive authority is regulated by:
x@ x@ x@ x@ x@ x@


A. The National Council of State Boards of Nursing
x@ x@ x@ x@ x@ x@ x@


B. The U.S. Drug Enforcement Administration
x@ x@ x@ x@


C. The State Board of Nursing for each state
x@ x@ x@ x@ x@ x@ x@


D. The State Board of Pharmacy
x@ x@ x@ x@




ANS: x @ C PTS: x @ 1

2. Physician Assistant (PA) prescriptive authority is regulated by:
x@ x@ x@ x@ x@ x@ x@


A. The National Council of State Boards of Nursing
x@ x@ x@ x@ x@ x@ x@


B. The U.S. Drug Enforcement Administration
x@ x@ x@ x@


C. The State Board of Nursing
x@ x@ x@ x@


D. The State Board of Medical Examiners
x@ x@ x@ x@ x@




ANS: x @ D PTS: x @ 1

3. Clinical judgment in prescribing includes:
x@ x@ x@ x@


A. Factoring in the cost to the patient of the medication prescribed
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@


B. Always prescribing the newest medication available for the disease process
x@ x@ x@ x@ x@ x@ x@ x@ x@


C. Handing out drug samples to poor patients
x@ x@ x@ x@ x@ x@


D. Prescribing all generic medications to cut costs
x@ x@ x@ x@ x@ x@




ANS: x @ A PTS: x @ 1

4. Criteria for choosing an effective drug for a disorder include:
x@ x@ x@ x@ x@ x@ x@ x@ x@


A. Asking the patient what drug they think would work best for them
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@ x@


B. Consulting nationally recognized guidelines for disease management
x@ x@ x@ x@ x@ x@


C. Prescribing medications that are available as samples before writing a prescription
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@


D. Following U.S. Drug Enforcement Administration (DEA) guidelines
x@ x@ x@ x@ x@ x@ x@


for prescribing
x@




ANS: x @ B PTS: x @ 1

5. Nurse practitioner practice may thrive under health-care reform due to:
x@ x@ x@ x@ x@ x@ x@ x@ x@


A. The demonstrated ability of nurse practitioners to control costs and improve p
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@ x@


atient outcomes x@


B. The fact that nurse practitioners will be able to practice independently
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@


C. The fact that nurse practitioners will have full reimbursement under health
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@


-care reform x@


D. The ability to shift accountability for Medicaid to the state level
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@




ANS: x @ A PTS: x @ 1